Break into the world's most competitive healthcare market — with the right relationships. Beyond Borders Marketing helps international pharmaceutical companies navigate U.S. market complexity with relationship-driven B2B strategies.
The U.S. generates more pharmaceutical revenue than any other market in the world, over $600 billion a year. But the path to that revenue is not straightforward. Decisions are spread across insurers, hospital systems, pharmacy networks and procurement committees, and none of them work the way they do in Europe or Asia. Knowing the market on paper is one thing. Knowing how it actually works is what separates companies that gain traction from those that stall. Overseas pharmaceutical companies that enter without that knowledge consistently run into the same four problems:
We understand the unique challenges international pharmaceutical companies face — from compliant messaging to building credibility with U.S. healthcare decision-makers. Here's why our pharma clients trust us:
U.S. pharma buyers make decisions differently than anywhere else. We help you understand who they are, how they buy and where to reach them.
U.S. pharma promotion has its own regulatory context. We build campaigns that work within those boundaries without slowing you down.
We help you identify the right channel partners, distributors and decision-makers, then build a strategy to get in front of them.
We use AI to sharpen research, targeting and execution. Every decision is reviewed and driven by people who know this market.
U.S. pharma runs on relationships. We get you in front of the right people through events, associations, content partnerships and speaking opportunities.
Before U.S. buyers trust you, they need to understand you. We build the positioning, sales tools and proof points that make that happen.
Targeted outbound campaigns across email and LinkedIn, from list building to booked meetings. Tracked, measured and adjusted based on what the data shows.
U.S. pharma buyers research before they take a meeting. We create the content that shows up when they do and keeps you visible between conversations.
We cater to a variety of sectors, ensuring tailored marketing strategies that resonate. From finance to education, our expertise spans multiple industries.
No. While we have deep expertise in pharma and life sciences, our cross-border B2B marketing approach works across healthcare sectors. We often serve medical device, biotech, and health technology companies alongside our pharma clients.
We are not a regulatory agency, but we build all content and campaigns with U.S. regulatory context in mind. We work alongside your regulatory and legal teams to ensure messaging is appropriate, accurate, and aligned with FDA guidelines.
Most engagements begin with a U.S. market assessment, followed by a go-to-market strategy. From there, we embed as your U.S. marketing partner — executing campaigns, building relationships, and reporting results on a regular cadence.
Most engagements begin with a U.S. market assessment, followed by a go-to-market strategy. From there, we embed as your U.S. marketing partner — executing campaigns, building relationships, and reporting results on a regular cadence.